Allogene Therapeutics schedules conference call for ALPHA3 trial data

April 10, 2026 4:02 PM

Allogene Therapeutics Inc. (NASDAQ: ALLO) will host a conference call on April 13, 2026, to present interim futility analysis data ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found